WATCH | SA's Biovac to manufacture Pfizer COVID-19 jab in SA

SA company Biovac has agreed to manufacture the Pfizer COVID-19 vaccine in South Africa. #eNCA's Heidi Giokos brings us the latest #DStv403

JOHANNESBURG - Pfizer and its German vaccine partner, Bio-NTech, have signed a letter of intent with the Biovac Institute, a company partially owned by the South African government.

The deal will see Pfizer start producing its COVID-19 vaccine destined for African nations at a facility in Cape Town.

READ: Pfizer/BioNTech to produce COVID-19 vaccine in SA

It is set to deliver more than 100-million doses annually, all of which will be distributed to over 50 member states of the African Union.

The financial terms of the agreement are yet to be disclosed.

Watch the video above for more details on this story.

Source
eNCA

Paid Content